Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
International Journal of Pharmaceutics|December 1, 2020
PEGylation of recombinant human deoxyribonuclease I decreases its transport across lung epithelial cells and uptake by macrophagesSohaib Mahri, Eléonore Hardy, Tobias Wilms, et al.Molecular Pharmaceutics|April 10, 2019
Cationic Nanoliposomes Are Efficiently Taken up by Alveolar Macrophages but Have Little Access to Dendritic Cells and Interstitial Macrophages in the Normal and CpG-Stimulated LungsRita Vanbever, Cristina Loira-Pastoriza, Nicolas Dauguet, et al.Particle and Fibre Toxicology|September 20, 2019
HIF-1α is a key mediator of the lung inflammatory potential of lithium-ion battery particlesViolaine Sironval, Mihaly Palmai-Pallag, Rita Vanbever, et al.International Journal of Pharmaceutics|March 23, 2021
Encapsulation of a CpG oligonucleotide in cationic liposomes enhances its local antitumor activity following pulmonary delivery in a murine model of metastatic lung cancerCristina Loira-Pastoriza, Kevin Vanvarenberg, Bernard Ucakar, et al.Protein Science : a Publication of the Protein Society|November 28, 2024
Enzymatic, structural, and biophysical characterization of a single-domain antibody (VHH) selectively and tightly inhibiting neutrophil elastase and exhibiting favorable developability propertiesPaola Redeghieri, Joël Moray, Frédéric Kerff, et al.Pharmaceutical Research|November 9, 2016
SPECT-CT Comparison of Lung Deposition using a System combining a Vibrating-mesh Nebulizer with a Valved Holding Chamber and a Conventional Jet Nebulizer: a Randomized Cross-over StudyJonathan Dugernier, Michel Hesse, Rita Vanbever, et al.Clinical Science (London, England : 1979)|June 7, 2018
Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputumMarie-Julie Guichard, David Kinoo, Anne-Sophie Aubriot, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|December 7, 2010
Nicotinamide enhances apoptosis of G(M)-CSF-treated neutrophils and attenuates endotoxin-induced airway inflammation in miceCláudia A Fernandes, Laurence Fievez, Bernard Ucakar, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 17, 2017
Fate of PEGylated antibody fragments following delivery to the lungs: Influence of delivery site, PEG size and lung inflammationHarshad P Patil, Danielle Freches, Linda Karmani, et al.Journal of Aerosol Medicine and Pulmonary Drug Delivery|December 8, 2010
The particle has landed--characterizing the fate of inhaled pharmaceuticalsJohn S Patton, Joseph D Brain, Lee A Davies, et al.Pageof 6